Ennab Farah, ElSaban Mariam, Khalaf Eman, Tabatabaei Hanieh, Khamis Amar Hassan, Devi Bindu Radha, Hanif Kashif, Elhassan Hiba, Saravanan Ketharanathan, Cremonesini David, Popatia Rizwana, Malik Zainab, Ho Samuel B, Abusamra Rania
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Department of Pediatrics, Mediclinic City Hospital, Dubai, United Arab Emirates.
JMIR Pediatr Parent. 2021 Nov 5;4(4):e29049. doi: 10.2196/29049.
COVID-19 has infected over 123 million people globally. The first confirmed case in the United Arab Emirates (UAE) was reported on January 29, 2020. According to studies conducted in the early epicenters of the pandemic, COVID-19 has fared mildly in the pediatric population. To date, there is a lack of published data about COVID-19 infection among children in the Arabian region.
This study aims to investigate the clinical characteristics, laboratory findings, treatment, and outcomes of children with COVID-19.
This cross-sectional, multicenter study included children with confirmed COVID-19 infection admitted to 3 large hospitals in Dubai, UAE, between March 1 and June 15, 2020. Serial COVID-19 polymerase chain reaction (PCR) testing data were collected, and patients' demographics, premorbid clinical characteristics, and inpatient hospital courses were examined.
In all, 111 children were included in our study and represented 22 nationalities. Of these, 59 (53.2%) were boys. The mean age of the participants was 7 (SD 5.3) years. About 15.3% of children were younger than 1 year. Only 4 (3.6%) of them had pre-existing asthma, all of whom had uneventful courses. At presentation, of the 111 children, 43 (38.7%) were asymptomatic, 68 (61.2%) had mild or moderate symptoms, and none (0%) had severe illness requiring intensive care. Fever (23/111, 20.7%), cough (22/111, 19.8%), and rhinorrhea (17/111, 15.3%) were the most common presenting symptoms, and most reported symptoms resolved by day 5 of hospitalization. Most patients had no abnormality on chest x-ray. The most common laboratory abnormalities on admission included variations in neutrophil count (22/111, 24.7%), aspartate transaminase (18/111, 22.5%), alkaline phosphatase (29/111, 36.7%), and lactate dehydrogenase (31/111, 42.5%). Children were infrequently prescribed targeted medications, with only 4 (3.6%) receiving antibiotics. None of the 52 patients tested for viral coinfections were positive. COVID-19 PCR testing turned negative at a median of 10 days (IQR: 6-14) after the first positive test. Overall, there was no significant difference of time to negative PCR results between symptomatic and asymptomatic children.
This study of COVID-19 presentations and characteristics presents a first look into the burden of COVID-19 infection in the pediatric population in the UAE. We conclude that a large percentage of children experienced no symptoms and that severe COVID-19 disease is uncommon in the UAE. Various laboratory abnormalities were observed despite clinical stability. Ongoing surveillance, contact tracing, and public health measures will be important to contain future outbreaks.
新型冠状病毒肺炎(COVID-19)已在全球感染超过1.23亿人。阿拉伯联合酋长国(阿联酋)的首例确诊病例于2020年1月29日报告。根据在疫情早期中心进行的研究,COVID-19在儿科人群中症状较轻。迄今为止,阿拉伯地区儿童COVID-19感染的公开数据尚缺。
本研究旨在调查COVID-19患儿的临床特征、实验室检查结果、治疗及转归。
这项横断面、多中心研究纳入了2020年3月1日至6月15日期间在阿联酋迪拜3家大型医院收治的确诊COVID-19感染患儿。收集了连续的COVID-19聚合酶链反应(PCR)检测数据,并对患者的人口统计学特征、病前临床特征及住院病程进行了检查。
本研究共纳入111名儿童,代表22个国籍。其中,59名(53.2%)为男孩。参与者的平均年龄为7(标准差5.3)岁。约15.3%的儿童年龄小于1岁。他们中只有4名(3.6%)有哮喘病史,所有这些患儿病程均平稳。就诊时,111名儿童中,43名(38.7%)无症状,68名(61.2%)有轻或中度症状,无(0%)有需要重症监护的严重疾病。发热(23/111,20.7%)、咳嗽(22/111,19.8%)和流涕(17/111,15.3%)是最常见的就诊症状,大多数报告的症状在住院第5天时缓解。大多数患者胸部X线无异常。入院时最常见的实验室异常包括中性粒细胞计数变化(22/111,24.7%)、天冬氨酸转氨酶(18/111,22.5%)、碱性磷酸酶(29/111,36.7%)和乳酸脱氢酶(31/111,42.5%)。儿童很少使用靶向药物,只有4名(3.6%)接受了抗生素治疗。52名接受病毒合并感染检测的患者均为阴性。COVID-19 PCR检测在首次阳性检测后的中位时间为10天(四分位间距:6 - 14天)转为阴性。总体而言,有症状和无症状儿童PCR结果转阴时间无显著差异。
这项关于COVID-19表现和特征的研究首次审视了阿联酋儿科人群中COVID-19感染的负担。我们得出结论,很大比例的儿童无症状,且严重COVID-19疾病在阿联酋并不常见。尽管临床稳定,但仍观察到各种实验室异常。持续监测、接触者追踪及公共卫生措施对于遏制未来疫情将很重要。